ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1239

Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis

Yukinori Okada1,2 and Toshihiro Tanaka3,4, 1Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 2Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 3Bioresource Research Center, Department of Human Genetics and Disease Diversity, Tokyo Medical and Dental University, Tokyo, Japan, 4Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epigenetics, Genetics and rheumatoid arthritis (RA), GWAS, MicroRNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: MicroRNA (miRNA), a short endogenous noncoding RNA, has a major role in the degradation and translational repression of a specific gene through its binding to 3′ UTR of such target mRNA. While biological contribution of miRNA has been reported, its impact on the genetics of human complex traits, especially in the context of miRNA-target gene networks, has not been assessed.

Methods: We developed a novel analytical method that comprehensively evaluates enrichment of genome-wide association study (GWAS) signals in miRNA-target gene networks. We obtained GWAS results of the 19 human complex traits, that comprises in total >1.75 million subjects. The association signals of the SNPs (i.e. p-values) were converted into the gene-based or miRNA-based association signals, adjusted by local linkage disequilibrium structures and gene/miRNA sizes. Relative enrichment of the association signals between miRNAs and target genes predicted by the multiple public databases (miRDB, miRmap, PITA, and TargetScan) was evaluated through permutation test (x10,000 iterations).

Results: Of the 19 evaluated human complex traits, rheumatoid arthritis (RA), estimated glomerular filtration rate (eGFR), and adult height showed significant enrichment of the association signals in miRNA-target gene networks (P < 0.05/19 = 0.0026; Figure 1). RA demonstrated the most significant results with 1.77-fold relative enrichment compared to the null hypothesis (P = 1.7x10-4�GFigures 1 and 2). Our method also provides a list of miRNA and target gene pairs with excess genetic association signals, part of which included drug target genes.

Conclusion: Our method clearly indicated significant impacts of miRNA-target gene networks on the genetics of human complex traits, especially implying their important roles in biology and drug discovery of RA.

 

Figure 1 GWAS signal enrichment in miRNA-target gene networks.

 

Figure 2 miRNA-target gene networks in RA GWAS

 


Disclosure: Y. Okada, None; T. Tanaka, None.

To cite this abstract in AMA style:

Okada Y, Tanaka T. Significant Impact of Microrna-Target Gene Networks on the Genetics of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/significant-impact-of-microrna-target-gene-networks-on-the-genetics-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/significant-impact-of-microrna-target-gene-networks-on-the-genetics-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology